333 related articles for article (PubMed ID: 11518857)
1. Blood pressure-independent effect of angiotensin AT1 receptor blockade on renal endothelin-1 production in hypertensive uremic rats.
Dumont Y; D'Amours M; Lebel M; Larivière R
J Hypertens; 2001 Aug; 19(8):1479-87. PubMed ID: 11518857
[TBL] [Abstract][Full Text] [Related]
2. Effects of losartan and captopril on endothelin-1 production in blood vessels and glomeruli of rats with reduced renal mass.
Larivière R; Lebel M; Kingma I; Grose JH; Boucher D
Am J Hypertens; 1998 Aug; 11(8 Pt 1):989-97. PubMed ID: 9715793
[TBL] [Abstract][Full Text] [Related]
3. Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats.
Lavoie P; Robitaille G; Agharazii M; Ledbetter S; Lebel M; Larivière R
J Hypertens; 2005 Oct; 23(10):1895-903. PubMed ID: 16148614
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
5. Supplementation with a low dose of L-arginine reduces blood pressure and endothelin-1 production in hypertensive uraemic rats.
Dumont Y; D'Amours M; Lebel M; Larivière R
Nephrol Dial Transplant; 2001 Apr; 16(4):746-54. PubMed ID: 11274268
[TBL] [Abstract][Full Text] [Related]
6. Endothelin ET(A) receptor blockade prevents the progression of renal failure and hypertension in uraemic rats.
Brochu E; Lacasse S; Moreau C; Lebel M; Kingma I; Grose JH; Larivière R
Nephrol Dial Transplant; 1999 Aug; 14(8):1881-8. PubMed ID: 10462266
[TBL] [Abstract][Full Text] [Related]
7. Renal and vascular effects of chronic nitric oxide synthase inhibition: involvement of endothelin 1 and angiotensin II.
D'Amours M; Lebel M; Grose JH; Larivière R
Can J Physiol Pharmacol; 1999 Jan; 77(1):8-16. PubMed ID: 10535660
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat.
Therrien F; Lemieux P; Bélanger S; Agharazii M; Lebel M; Larivière R
Eur J Pharmacol; 2009 Apr; 607(1-3):126-34. PubMed ID: 19326569
[TBL] [Abstract][Full Text] [Related]
9. Increased immunoreactive endothelin-1 levels in blood vessels and glomeruli of rats with reduced renal mass.
Larivière R; D'Amours M; Lebel M; Kingma I; Grose JH; Caron L
Kidney Blood Press Res; 1997; 20(6):372-80. PubMed ID: 9453448
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II receptor blockade unmasks a depressor response to endothelin antagonists in rats.
Richard V; Hogie M; Thuillez C
Fundam Clin Pharmacol; 2000; 14(2):101-6. PubMed ID: 10796056
[TBL] [Abstract][Full Text] [Related]
11. Losartan but not verapamil inhibits angiotensin II-induced tissue endothelin-1 increase: role of blood pressure and endothelial function.
d'Uscio LV; Shaw S; Barton M; Lüscher TF
Hypertension; 1998 Jun; 31(6):1305-10. PubMed ID: 9622146
[TBL] [Abstract][Full Text] [Related]
12. Losartan increases NO release in afferent arterioles during regression of L-NAME-induced renal damage.
Helle F; Iversen BM; Chatziantoniou C
Am J Physiol Renal Physiol; 2010 May; 298(5):F1170-7. PubMed ID: 20219827
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive effects of a mixed endothelin-A- and -B-receptor antagonist, J-104132, were augmented in the presence of an AT1 -receptor antagonist, MK-954.
Ikeda T; Ohta H; Okada M; Kawai N; Nakao R; Siegl PK; Kobayashi T; Miyauchi T; Nishikibe M
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S337-41. PubMed ID: 11078414
[TBL] [Abstract][Full Text] [Related]
14. Roles of AT1 and AT2 receptors in the hypertensive Ren-2 gene transgenic rat kidney.
Zhuo J; Ohishi M; Mendelsohn FA
Hypertension; 1999 Jan; 33(1 Pt 2):347-53. PubMed ID: 9931128
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.
Chamorro V; Wangensteen R; Sainz J; Duarte J; O'Valle F; Osuna A; Vargas F
Clin Sci (Lond); 2004 Mar; 106(3):251-9. PubMed ID: 14521506
[TBL] [Abstract][Full Text] [Related]
16. Effects of AT1 receptor blockade on blood pressure and the renin-angiotensin system in spontaneously hypertensive rats of the stroke prone strain.
Wagner J; Drab M; Bohlender J; Amann K; Wienen W; Ganten D
Clin Exp Hypertens; 1998 Feb; 20(2):205-21. PubMed ID: 9533614
[TBL] [Abstract][Full Text] [Related]
17. Despite similar reduction of blood pressure and renal ANG II and ET-1 levels aliskiren but not losartan normalizes albuminuria in hypertensive Ren-2 rats.
Vaňourková Z; Kramer HJ; Husková Z; Cervenka L; Vaněčková I
Physiol Res; 2010; 59(3):339-345. PubMed ID: 20666571
[TBL] [Abstract][Full Text] [Related]
18. Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve increased renal angiotensin II concentrations.
Verhagen AM; Braam B; Boer P; Gröne HJ; Koomans HA; Joles JA
Kidney Int; 1999 Jul; 56(1):222-31. PubMed ID: 10411696
[TBL] [Abstract][Full Text] [Related]
19. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of losartan and amlodipine regarding long-term blood pressure, cardiac and renal protection.
Peng F; Lin J; Lin L; Tang H
Int J Mol Med; 2012 Dec; 30(6):1376-86. PubMed ID: 23064712
[TBL] [Abstract][Full Text] [Related]
20. Thromboxane blockade reduces blood pressure and progression of renal failure independent of endothelin-1 in uremic rats.
Larivière R; Moreau C; Rodrigue ME; Lebel M
Prostaglandins Leukot Essent Fatty Acids; 2004 Aug; 71(2):103-9. PubMed ID: 15207526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
